Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Ocular Sarcoidosis Open Label Trial of ACTHAR Gel
Brief Summary: Treatment with ACTHAR Gel will result in a reduction of ocular inflammation in patients with active ocular sarcoidosis that requires systemic immunosuppressant therapy (hypothesis)